These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 20645222

  • 1. GLP-1 (9-36) amide metabolite suppression of glucose production in isolated mouse hepatocytes.
    Tomas E, Stanojevic V, Habener JF.
    Horm Metab Res; 2010 Aug; 42(9):657-62. PubMed ID: 20645222
    [Abstract] [Full Text] [Related]

  • 2. GLP-1-derived nonapeptide GLP-1(28-36)amide targets to mitochondria and suppresses glucose production and oxidative stress in isolated mouse hepatocytes.
    Tomas E, Stanojevic V, Habener JF.
    Regul Pept; 2011 Apr 11; 167(2-3):177-84. PubMed ID: 21256872
    [Abstract] [Full Text] [Related]

  • 3. In vitro metabolism of the glucagon-like peptide-1 (GLP-1)-derived metabolites GLP-1(9-36)amide and GLP-1(28-36)amide in mouse and human hepatocytes.
    Sharma R, McDonald TS, Eng H, Limberakis C, Stevens BD, Patel S, Kalgutkar AS.
    Drug Metab Dispos; 2013 Dec 11; 41(12):2148-57. PubMed ID: 24056839
    [Abstract] [Full Text] [Related]

  • 4. Glucagon-like peptide-1(9-36)amide metabolite inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E, Wood JA, Stanojevic V, Habener JF.
    Diabetes Obes Metab; 2011 Jan 11; 13(1):26-33. PubMed ID: 21114600
    [Abstract] [Full Text] [Related]

  • 5. The major glucagon-like peptide-1 metabolite, GLP-1-(9-36)-amide, does not affect glucose or insulin levels in mice.
    Rolin B, Deacon CF, Carr RD, Ahrén B.
    Eur J Pharmacol; 2004 Jun 28; 494(2-3):283-8. PubMed ID: 15212985
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis.
    Tomas E, Habener JF.
    Trends Endocrinol Metab; 2010 Feb 28; 21(2):59-67. PubMed ID: 20018525
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and metabolism studies on the glucagon-like peptide-1 (GLP-1)-derived metabolite GLP-1(9-36)amide in male Beagle dogs.
    Eng H, Sharma R, McDonald TS, Landis MS, Stevens BD, Kalgutkar AS.
    Xenobiotica; 2014 Sep 28; 44(9):842-8. PubMed ID: 24588343
    [Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
    Lee YS, Shin S, Shigihara T, Hahm E, Liu MJ, Han J, Yoon JW, Jun HS.
    Diabetes; 2007 Jun 28; 56(6):1671-9. PubMed ID: 17369525
    [Abstract] [Full Text] [Related]

  • 9. The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans.
    Meier JJ, Gethmann A, Nauck MA, Götze O, Schmitz F, Deacon CF, Gallwitz B, Schmidt WE, Holst JJ.
    Am J Physiol Endocrinol Metab; 2006 Jun 28; 290(6):E1118-23. PubMed ID: 16403774
    [Abstract] [Full Text] [Related]

  • 10. GLP-1-derived nonapeptide GLP-1(28-36)amide inhibits weight gain and attenuates diabetes and hepatic steatosis in diet-induced obese mice.
    Tomas E, Wood JA, Stanojevic V, Habener JF.
    Regul Pept; 2011 Aug 08; 169(1-3):43-8. PubMed ID: 21549160
    [Abstract] [Full Text] [Related]

  • 11. Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in mice.
    Riedel MJ, Lee CW, Kieffer TJ.
    Am J Physiol Endocrinol Metab; 2009 Apr 08; 296(4):E936-44. PubMed ID: 19190262
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
    Ban K, Noyan-Ashraf MH, Hoefer J, Bolz SS, Drucker DJ, Husain M.
    Circulation; 2008 May 06; 117(18):2340-50. PubMed ID: 18427132
    [Abstract] [Full Text] [Related]

  • 13. GLP-1-derived nonapeptide GLP-1(28-36)amide represses hepatic gluconeogenic gene expression and improves pyruvate tolerance in high-fat diet-fed mice.
    Ip W, Shao W, Chiang YT, Jin T.
    Am J Physiol Endocrinol Metab; 2013 Dec 01; 305(11):E1348-58. PubMed ID: 24085036
    [Abstract] [Full Text] [Related]

  • 14. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL, Huang Q, Cao X, Drucker DJ.
    Gastroenterology; 2008 Apr 01; 134(4):1137-47. PubMed ID: 18313669
    [Abstract] [Full Text] [Related]

  • 15. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J, Longuet C, Baggio LL, Li K, Drucker DJ.
    Gastroenterology; 2010 Sep 01; 139(3):857-68. PubMed ID: 20546737
    [Abstract] [Full Text] [Related]

  • 16. GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide.
    Elahi D, Egan JM, Shannon RP, Meneilly GS, Khatri A, Habener JF, Andersen DK.
    Obesity (Silver Spring); 2008 Jul 01; 16(7):1501-9. PubMed ID: 18421270
    [Abstract] [Full Text] [Related]

  • 17. Characterization of [¹²⁵I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta.
    Kuc RE, Maguire JJ, Siew K, Patel S, Derksen DR, Margaret Jackson V, O'Shaughnessey KM, Davenport AP.
    Life Sci; 2014 May 02; 102(2):134-8. PubMed ID: 24641952
    [Abstract] [Full Text] [Related]

  • 18. Role of GLP-1 induced glucagon suppression in type 2 diabetes mellitus.
    Hare KJ.
    Dan Med Bull; 2010 Sep 02; 57(9):B4181. PubMed ID: 20816021
    [Abstract] [Full Text] [Related]

  • 19. Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor.
    Nuche-Berenguer B, Portal-Núñez S, Moreno P, González N, Acitores A, López-Herradón A, Esbrit P, Valverde I, Villanueva-Peñacarrillo ML.
    J Cell Physiol; 2010 Nov 02; 225(2):585-92. PubMed ID: 20506394
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattle.
    ThanThan S, Saito T, Yannaing S, Zhao H, Nakashima K, Kuwayama H.
    Domest Anim Endocrinol; 2012 Apr 02; 42(3):155-64. PubMed ID: 22154917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.